NewslettersImmunology of Infectious Disease NewsFDA Approves First Respiratory Syncytial Virus (RSV) VaccineBy Bob - May 3, 20230252The US FDA approved Arexvy, the first RSV vaccine approved for use in the United States. Arexvy is approved for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.[FDA]Press Release